Dr. Neha Mishra
“Every patient deserves a physician who reads the evidence carefully — and a healthcare system that communicates it honestly.”
Clinical Precision. Evidence-Based Review.
Dr. Neha Mishra is a board-certified physician in Internal Medicine with subspecialty expertise in Infectious Disease, bringing over 12 years of clinical practice and medical research experience to her role as Medical Reviewer for Sunny Pharma®. Her clinical career has spanned hospital medicine, outpatient infectious disease consultations, and community health programs focused on HIV and Hepatitis C care in underserved populations across South Asia and North America.
Dr. Mishra completed her MBBS and MD in Internal Medicine before undertaking advanced clinical training in Infectious Disease, where she developed a particular focus on antiretroviral therapy optimization, Hepatitis C direct-acting antiviral regimens, and the pharmacological management of co-infected patients. Her research has examined real-world treatment outcomes in HIV-positive populations in India, adherence barriers in Hepatitis C therapy, and the pharmacokinetics of generic antiretroviral formulations.
As a medical reviewer for Sunny Pharma®, Dr. Mishra applies the same rigorous clinical lens she uses in practice to every article she reviews. Her role is to ensure that all drug information, treatment guides, and patient-facing content accurately reflects current prescribing standards, clinical trial evidence, and international treatment guidelines including WHO, DHHS, and AASLD/IDSA recommendations. She brings an invaluable global perspective — having practiced medicine and contributed to clinical research across India, the United Kingdom, and Canada — ensuring that Sunny Pharma® content speaks to patients from all backgrounds and healthcare systems.
Every patient deserves a physician who reads the evidence carefully — and a healthcare system that communicates it honestly. That is what I bring to every review I conduct for Sunny Pharma®.
Published Work & Journal Contributions
A selection of Dr. Mishra’s peer-reviewed publications and clinical contributions across infectious disease, HIV pharmacotherapy, and Hepatitis C therapeutics.
-
Real-World Virological Outcomes of Bictegravir-Based Regimens in Treatment-Naive HIV Patients: A South Asian Cohort Study
-
Generic vs Branded Antiretrovirals: A Bioequivalence and Clinical Outcomes Review for Prescribing Physicians
-
Adherence to Direct-Acting Antiviral Therapy in Hepatitis C Patients from Low-Income Settings: A Prospective Cohort Analysis
-
Dolutegravir Safety in Pregnancy: A Clinical Review of Emerging Evidence and Communication Strategies for Patients
-
HIV-HCV Co-Infection Management: Updated Treatment Pathways and Drug Interaction Considerations
-
Sofosbuvir/Velpatasvir in Genotype 3 Hepatitis C: Clinical Outcomes and Patient Counseling Framework
-
Barriers to HIV Treatment Access in Urban India: A Mixed-Methods Study with Implications for Pharmacy-Based Interventions
-
PrEP Knowledge and Uptake Among High-Risk Populations in Mumbai: A Cross-Sectional Survey
-
Pharmacovigilance of Antiretroviral Therapy in Resource-Limited Settings: A Systematic Review
Review Standards & Conflict of Interest
All content reviewed by Dr. Neha Mishra for Sunny Pharma® is evaluated against current FDA prescribing information, WHO HIV and HCV treatment guidelines, DHHS Adult ARV Treatment Guidelines, and AASLD/IDSA HCV Guidance. She applies the same evidence standards she uses in direct patient care, ensuring that every reviewed article is clinically accurate, appropriately caveated, and suitable for a patient-facing audience. Dr. Mishra has no financial relationships with any antiretroviral or antiviral pharmaceutical manufacturer. Her compensation from Sunny Pharma® is a fixed review fee, independent of all commercial outcomes.
Last credentials verified: January 2025 | Editorial oversight: Wendy Chamberlain, MD, MPH, Editor-in-Chief